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• Sex differences exist in the behavioral patterns of adult 
vertebrate species. Many of these behavioral differences arise 
as a, result of the developmental imprinting of sex specific pat- 
terns in the anatomical, biochemical and molecular substrates 
of the brain. It is well established that steroid hormones play 
an important role during critical periods of development to or- 
ganize the brain to a male or female specific pattern. In order 
to demonstrate that these hormones can act directly on brain 
tissue, ligand specific receptors for estrogen and androgen 
have been demonstrated in the developing brain, using a va- 
riety of techniques. Each class of steroid hormone receptor 
exhibits a unique distribution in the brain. Furthermore, each 
receptor undergoes a unique and tissue specific ontogenetic 
pattern of expression. A careful examination of the distribu- 
tion and ontogeny of expression allows one to formulate spe- 
cific hypotheses regarding the role of each of these receptors 
in the development and maturation of the brain. (Biomed Rev 
1997; 7: 51-66) 
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• It is known that gonadal steroid hormones can act dur- 
ing development to organize the brain in a male or female direc- 
tion (reviewed in 1). The consequences of gonadal steroid hor- 
mone induced brain differentiation ultimately affect adult physi- 
ology including many aspects of reproductive behavior (2), 
neuroendocrine function (2), cognitive function (3-5) and other 
(6, 7). To determine the mechanisms by which estrogen and 
androgen can influence the development of the brain, studies 
have examined the receptors for gonadal steroid hormones in 
the brains of adult and neonatal animals. These studies have 
led to the generation of multiple hypotheses regarding the role 
played by these-hormones in the Cellular processes of sexual 
differentiation of the brain. Underlying these hypotheses are 
the observations that steroid hormone receptors are present in 
sexually differentiated brain areas during the period of time 
which the tissue is undergoing organization and maturation. 
This survey briefly reviews the localization, ontogeny and regu- 
lation of estrogen receptors (ER) and androgen receptors (AR) 
in the developing brain. 
•         Mechanisms of steroid hormone action 
The ER and AR belong to the superfamily of ligand-activated 
nuclear transcription factors which include receptors for other 
steroid hormones such as glucocorticoids and mineralocorti- 
coids, as well as vitamin D, retinoic acid, thyroid hormone, and 




mone receptors are soluble, high molecular weight intracellular 
proteins which bind their ligands, 17-J3 estradiol for estrogen 
receptor (ER), testosterone or dihydrotestosterone for andro- 
gen receptor (AR), with high affinity, Kd approximately 1-2x10" 
1(1 M. In the presence of ligand, the receptor is rapidly trans- 
formed from an inactive to an active state (9). Transformation 
results in the transcriptional regulation of steroid hormone re- 
sponsive genes (10). 
It is now well established that the untransibrmed steroid recep- 
tor exists as a multiprotein complex associated with heat shock 
protein (hsp). It is thought that unbound receptors are unable 
to bind DNA due to the masking of a DNA-binding domain in 
the receptor by hsp90 (11) .  Following ligand binding, hsp90 is 
dissociated from the complex leaving an active form with a high 
affinity for DNA (12). Untransibrmed receptor is also thought 
to complex with a variety of other receptor-associated proteins 
including hsp70 and hsp56 (13). The function of these additional 
proteins is not yet known, however some, such as the recently 
described ER-associated protein (ERAP) (14), and an androgen 
receptor-associated protein (ARAP) may function to modulate 
the receptor's ability to induce transcription (15). 
Ligand binding to the receptor also induces the formation of 
receptor dimers which are important for recognition and tight 
binding of the receptor to the response element on DNA (16). 
The response elements on DNA are comprised of inverted re- 
peals with the two half sites separated by a three nucleotide gap. 
The palindromic sequence of the DNA response element and 
the two fold rotational symmetry suggest that the nuclear re- 
ceptors bind DNA as dimer (17, 18). DNA-binding specificity 
lor  the nuclear hormone receptors is determined, in part, by 
three residues in the first finger of a zinc region in the DNA- 
binding domain of the receptor (19).  
Target gene specificity may also be conferred by variations 
between different hormone response elements on DNA, by cell- 
or tissue-specific regulation of receptor levels, by additional 
transcription factors which may be necessary for full receptor 
activity (20), or by tissue-specific hormone metabolism (21). 
Additional factors in forming a "complex response element" may 
be involved in directing target gene specificity and in dictating 
whether the receptor upregulatcs or downregulates transcrip- 
tion. Examples of these have been demonstrated for glucocorti- 
coid, mineraloeorticoid, estrogen and androgen responsive pro- 
moter (22-26). 
ESTROGEN RECEPTORS 
• Typical of all member of the steroid hormone receptor su- 
perfamily, the ER is composed of six distinct cassettes or func- 
t ional domains (Fig. 1; 27-29). The amino terminus (A/B) is 
hypervariablc and is probably important for regulation and 
specificity of transcription by theER. Antibodies against ER are 
generally directed against this region. Region C is the DNA- 
binding domain and is important in determining target gene 
specificity (27). The general structure of this region is highly 
conserved among member of the steroid hormone superfamily 
and suggests that it performs functions common to all of the re- 
ceptors (30). Region D is a poorly conserved, hydrophilic domain 
which can be altered by amino acid deletions without affecting 
ER function (29, 31). The steroid-binding domain (region E) is 
believed to bind the ligand by forming a hydrophobic pocket 
(27). Region E also contains a region for dimerization of the re- 
ceptor (32) and for ligand-dependent transcriptional activation 
(33,34). The poorly conserved C-terminal region (F) can be de- 
leted without affecting hormone binding or transcriptional acti- 
vation (29). 
A single form of ER was originally cloned and described for 
multiple species including the human (27) and rat (28). Re- 
cent studies have shown that, in fact, two forms of ER exist. 
Thus, the originally cloned receptor has been designated ERa, 
whereas the newly cloned receptor has been designated ERp 
(35, 36). Both forms of ER exist in the brain (37, 38) possess a 
high affinity for estradiol and maintain a common domain struc- 
ture characteristic of steroid hormone receptors. Consequently, 
although the original studies examining ER binding probably 
detected both receptor forms, studies using antibodies gener- 
ated against ERp or probes hybridizing to mRNAHR(i may not 
necessarily include the P form of receptor. This may help ex- 
plain some of the reported inconsistencies in the distribution of 
ER using binding or in situ hybridization techniques (37, 39). 
mRNAHR isoforms have also been described. An isoform of 
mRNAHKa lacking exon four, encoding a portion of the ligand- 
binding domain, has been demonstrated in the hypothalamus 
(40). Similarly, a smaller form of mRNAKRa has been shown 
by Northern blot analysis in anterior pituitary (41, 42). Re- 
cently, it has been shown that mRNAKRr* possesses multiple 5'- 
untranslated regions (5'-UTR), which are variably spliced onto 
the first coding exon of the mRNA. These are found at high lev- 
els in brain but each with region selectivity. This suggests a 
differential regulation of the translation of mRNAKRcc in various 
brain areas (43). The functional significance of these ERa 
isoforms remains to be determined. The possibility exists that 
changes in these mRNAHR(I isoforms may occur during devel- 
opment and differentially regulate the sensitivity of developing 
brain regions to estrogen. 
•         Distribution of estrogen receptors in the brain 
ER were initially localized in the adult CNS by in vivo autorad- 
iography (44-46). This anatomical distribution coincides with the 
regions known to mediate many gonadal steroid dependent re- 
productive behaviors and functions (47,48). Similar anatomical 
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Figure 1. Schematic diagram showing the domain structure of the estrogen receptor (ER) (A). The box represents the protein 
coding region. Region A/B is the hypervariable, amino terminal domain; C is the DNA-binding domain; D is the hydrophilic 
domain; E is the ligand-binding domain which contains subdomains for hormone-relieved trancriptional inactivation (Ti) and 
receptor dimerization (dimer); F is the poorly conserved carboxy terminal domain. The single line represents the 5'- and 3'- 
untranslated regions of the mRNA
ER
. A dimer of two estrogen receptors each bound to an estrogen response element (ERE) half 













distributions for ER and mRNAhlia have been shown using im- 
munoeytochemistry (49) and in situ hybridization histochemis- 
try (37). In general, in the adult brain. ER and mRNAKR are found 
in the periventricular and medial zones of the hypothalamus, with 
greatest levels in the anteroventral periventricular nucleus, the 
arcuate nucleus, the central and medial parts of the medial 
preoptic nucleus, the posterodorsal preoptic nucleus, and the 
ventrolateral part of the ventromedial nucleus. High levels of 
ER arc also found in the medial amygdala and amygdalo-hip- 
pocampal area, the cortical amygdala, parts of the bed nucleus 
of stria terminalis (BNST) and ventral lateral septum. 
High levels of ER have also been detected in the neonatal cor- 
tex and hippocampus (50, 51), whereas, in the adult hippoc- 
ampus, only low ER concentrations have been found. In the 
adult, ER have been localized primarily to the CA1 pyramidal 
layer, layer IV of the entorhinal cortex, and interneurons of the 
hilar infragranular zone and of the ventral subicular molecu- 
lar layer using immunocytochemistry, autoradiography, and in 
vitro binding assays (45, 52-55). In contrast to the rat, a sub- 
stantial concentration of ER-eontaining neurons has been re- 
ported throughout the rostrocaudal extent of the adult female 
guinea pig hippocampus (56) with greatest levels of ER-im- 
munoreactivily in the amygdalo-hippocampal transition zone 
and the infragranular zone of the dentate gyrus and in the 
subiculum. A potential sex difference in entorhinal and corti- 
cal ER-immunorcactivity is suggested by the finding of labeled 
cells in the diestrous, virgin and pregnant mouse hippocam- 
pus and entorhinal cortex, but no ER-immunoreactivity is seen 
in these same regions of the male mouse (49). 
•         Development of estrogen receptors in the hypothalamus 
In the rodent, sexual differentiation of brain areas controlling 
reproductive function and behaviors depend on the presence 
of estrogen which results from the intraccllular conversion of 
testosterone to estrogen by the enzyme aromatase (see Beyer 
and Hutchison [57] in this volume of' Biomedical Reviews). 
Aromalase has been shown to be present in hypothalamic nu- 
clei during development (58). Presumably, aromatase derived 
eslrogen acts by binding to ER which are present in hypotha- 
lamic brain nuclei during the critical period of sexual differ- 
entiation. 
Previous studies have described the ontogeny of ER in the 
hypothalamus of the rat (50,59), monkey (60), and mouse (61). 
In general, ER are first found in rat hypothalamus during prena- 
tal development. ER have been detected by at least embryonic 
day 17-20 (59, 62). In the opossum, a marsupial which is born in 
a sexually undifferentiated state, ER-immunoreactivity has been 
shown in the peri ventricular hypothalamus, medial preoptic area 
(MPOA), lateral septum, BNST, amygdala, arcuate nucleus and 
ventromedial nucleus (VMN) of the hypothalamus by postna- 
tal day 15 which is approximately the developmental age when 
ER first appears in the rat brain. Increases in ER-immunoreac- 
tivity occur in these areas until adulthood (63). 
In the rat hypothalamus, it appears that the density of ER in- 
creases relatively linearly from birth through the first several 
weeks of postnatal life (50, 51, 59). This is not the case for 
mRNAHRp, since in the MPOA of female rats, mRNAhRa is high- 
est on postnatal day (PND) 4 and then declines to adult levels 
(64). Changes in the levels of mRNAHR may not always parallel 
the changes in protein and binding (37, 39). However, since all 
studies examining mRNAKR in the brain to date have focused 
on the mRNAhRa, the possibility remains that the mRNAKR|5 may 
be regulated in a fashion which allows for parallel changes to 
occur between ER and its mRNA when examined in total. An 
example of this is seen in the developing hippocampus. Al- 
though O'Keefe and Handa (51) report 2-3 fold increases in 
estrogen binding in neonatal hippocampus between PND 0 and 
PND 4-7, the examination of mRNA levels using a highly quan- 
titative RNAse protection assay shows a much more modest 
increase (60%) in mRNAKRct during the same time period (41), 
However, with the cloning of ERp, Price and Handa (65) reexam- 
ine the transient expression of mRNAHR in the hippocampus. 
Their results demonstrate that coincident with the rise in 
mRNARRa at PND 4, there is a rise in mRNARRp. This suggests 
that increases in hippocampal ER binding during neonatal life 
may actually reflect increases in the steady-state levels of both 
ERa and ERP genes. 
Sex differences in ER binding levels have been shown in adult- 
hood (66) and these differences may be present early in devel- 
opment. In adult rats, females have higher levels of ER in the 
MPOA and VMN than males (66). These differences are re- 
flected by sex differences in mRNAHR[i levels (67). Interestingly, 
females have also been reported to have higher levels of ER (68) 
and mRNAHRp (64) in the MPOA during postnatal life. Thus, the 
high levels of mRNAKRa in females may reflect differences in 
levels of aromatizable androgens, and consequently, estrogenic 
metabolites. ERoc mRNA has been shown to be reduced by es- 
trogen in the MPOA of the adult male and female (67, 69). This 
would suggest that the lower levels of mRNAhRa in males re- 
flect in vivo activation of ER. In support of this hypothesis, 
neonatal castration of male rats increases mRNAhRa levels in the 
MPOA on PND 4, and treatment of females with diethylstil- 
besterol, but not dihydrotestosterone, reduce mRNAhRa levels 
to that of the male (70). 
• Development of estrogen receptors in extrahypotha- 
lamic brain areas 
Studies have implicated estrogen in the physiology of extra- 
hypothalamic brain areas of the adult. Evidence that ER and 
mRNAHR are expressed in the hippocampus and cortex of the   
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adult rat (37, 52, 54,, 71) and guinea pig (56), suggests a direct 
mode of action by which estrogen can influence cortical and 
hippocampal function. Interestingly, in almost every case, ER 
are found in relatively low levels in adult rat hippocampus and 
cortex. On the other hand, studies have demonstrated that ER 
arc found at high levels in the cortex (72) and hippocampus (51) 
of the neonatal rat. The high levels of expression of ER in these 
(issues is transient and exists only during development. The 
transient expression of ER in these tissues may be useful for 
defining a critical period of development where certain tissues 
arc most sensitive to the actions of estrogen. 
In cortical tissues it has been shown that ER is found at high 
levels during the first 2-3 weeks of postnatal life (50, 51). Fur- 
thermore, it has been shown that ER are present in migrating 
cells during differentiation and the establishment of connec- 
tions. This suggests that ER may play a role in these processes 
(72). This finding supplements the previous reports that treat- 
ment of cortical organotypic cultures of cingulate/frontal cor- 
tex with  estrogen enhances neurite outgrowth (73) and in- 
creases protein synthesis. In contrast, MacLusky etal (50) have 
questioned whether these cortical ER are functional since they 
were unable to demonstrate receptor occupation by endogenous 
levels of estrogen.  
Studies in the hippocampus have shown that parallel changes 
occur with those seen in cortical tissues. However, the transient 
increase in ER in hippocampus occurs earlier than that of cor- 
icx. with peak levels at about PND 4-7 (51; see Fig.2). This in- 
crease is accompanied by increases in mRNAHR (41,65). Unlike 
the distribution of ER in the adult hippocampus, the distribu- 
tion of mRNAHKa in the neonate appears to be more uniform 
throughout the pyramidal cell layer, with slightly higher levels 
in CA3 and lower ones in the dentate gyrus granule cells (41). 
Transient increases in ER and mRNAHR have also been shown 
in the auditory cortex (74) and the facial nucleus (75-77). It is 
suggested that they may be involved in the maturation of the 
auditory system since the ER-conlaining cells in the facial nucleus 
project to the posterior auricular muscles (75). 
•         Regulation of estrogen receptors during development 
Few studies have examined the factors which cause ER to be 
expressed or not expressed in various tissues during develop- 
ment. Using in vitro autoradiography, Kuhnemann et al (78) 
have demonstrated that castration of male rats at birth increase 
ER levels in the preoptic area and ventromedial and arcuate 
nucleus, whereas injection of female rats at birth with testoster- 
one propionate decreases ER binding. Consistent with these ob- 
servations,  DonCarlos et al (70) have demonstrated that 
niRNA11<p can be autologously regulated by estrogen in the neo- 
nate. In these studies, castration of male rats increases mRNAhR'3 
whereas treatment of female neonates with diethylstibesterol 
reduces mRNAKR|5 to the level of the male. 
These studies suggest that autoregulation of transcription is 
present in the neonate, in a fashion similar to that described 
in the adult (67, 69, 79, 80). However, little is known about 
the intracellular factors which regulate developmental increases 
in ER. Using a heterochronic and heterotopic transplant para- 
digm, O'Keefe etal ( S I )  and Pederen et al (82) have determined 
that factors driving the transient developmental increases in ER 
in the hippocampus and cortex are determined early in gesta- 
tion, and are an inherent developmental program to which the 
tissue is committed. Similar results have been shown for hypo- 
thalamus (81, 83). Transplantation of neonatal hypomalamic tis- 
sue to the cortex (81) or the choroidal pia overlying the superior 
colliculus (83) does not alter the developmental pattern of ER 
expression. Furthermore, the appearance of ER is not dependent 
on donor sex or gonadal steroid environment (83). Thus, al- 
though these studies do not determine the intracellular factors 
responsible for developmental increases in ER, they do appear 
to rule out paracrine and endocrine factors as influencing the 
autonomous, region specific developmental profile of ER expres- 
sion. 
ANDROGEN RECEPTORS 
• Characterization and distribution of androgen recep- 
tors in the brain 
Early studies, using in vivo receptor autoradiography, demon- 
strated specific patterns of radio!abeled hormone uptake by cells 
in the central nervous system of the adult (84). Androgen con- 
centrating cells were shown to have a relatively wide distribu- 
tion throughout the brain of many species including the rat (85), 
guinea pig (86), non-human primate (87) and sheep (88). Most 
notably, androgen concentrating cells were found at relatively 
high levels in specific nuclei of the brain including the VMN, 
arcuate nucleus, periventricular nucleus, MPOA, BNST, hippoc- 
ampal CA1 pyramidal cells, and medial amygdala. Subsequent 
studies, using in vitro binding assays, showed that following 
cell fractionation, cytosolic preparations, and nuclear salt ex- 
tracts of tissue taken from specific brain regions contained a 
single, saturable receptor for radiolabeled dihydrotestosterone 
or Rl 881, a synthetic androgen, with a high affinity for ligand 
(0.2-2 nM) (89, 90). Quantitation of the levels of AR, using in 
vitro binding assays on microdissected brain tissue, revealed a 
similar brain distribution and relative amount of AR (90) as that 
revealed by in vivo autoradiographic techniques. Finally, the 
dynamics of the AR were revealed by the use of in vitro bind- 
ing assay. That is, in the absence of ligand, such as following 
castration of male rats, most receptors are found in the cytoso- 
lic or unoccupied form. Following treatment of animals with hor- 
mone, the receptors become occupied and are measurable fol-   
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Figure 2. Developmental profile of estrogen receptors in the hippocampus, frontal cortex and hypothalamus/preoptic area of the rat Each point represents 
the mean ± SEM. Postnatal day 0, day of birth. No significant sex differences are detected and thus, data from males and females are combined for this figure. 
From Ref. 51, with permission . 
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lowing extraction from nuclei by high salt buffer (91,92). 
Recent studies have used immunocytochemical and molecular 
techniques to accurately map the distribution of the AR and their 
inRNA in the brain. In most cases, the distribution of AR-immu- 
norcactivity and mRNAAK match that described for AR using 
autoradiography (37, 93, 69). An example of the distribution of 
mRNAAli is shown in Fig.3. In this study, in situ hybridization 
was performed using a probe detecting both known forms of 
niRNAAli and thus, represents the distribution of total mRNAAR. 
Early studies, examining the differential effects of testosterone 
and dihydrotestosterone on a variety of end points, suggested 
the possibility that two specific AR existed, one for testoster- 
one and another for dihydrotestosterone (94). It now appears 
that AR are transcribed from a single gene of approximately 75-90 
Kb (95). However, differences in the functional capacity of tes- 
tosterone and dihydrotestosterone to activate gene expression 
appear to be related to their relative differences in interacting 
wi th a single AR. Dihydrotestosterone possesses a stronger af- 
f in i ty  for the AR, stabilizes the receptor to a greater extent than 
testosterone, and may cause conformational changes in the AR 
which allows it to interact with  the androgen response element 
on DNA more efficiently (96). 
Studies have also shown that the mRNAAI< exists in several forms 
in the rat brain. Although the predominant form of mRNAAR in 
peripheral tissues is one of approximately 10-11 Kb, a second 
smaller form of mRNAAR (approximately 9.0-9.5 Kb) exists in brain 
at relatively high levels (97, 98). In some tissues, such as the 
cortex, this smaller form of mRNAAI< predominates (97). Using 
5'- RACE to amplify the untranslated region of the small form of 
mRNAAR, Price and Handa (99) demonstrate that the smaller form 
ol'mRNAAI< is due, in part, to the presence of a truncated 5'-UTR. 
Studies examining the 5'-UTR of AR have shown that removal 
of the 5'-UTR results in a decreased translational efficacy (100), 
thus suggesting that the presence of the smaller form of mRNAAR 
in hrain tissue may represent an additional mechanism used by 
neural tissues to regulate AR translation. 
•         Ontogeny of androgen receptors in the brain 
A role for AR in the sexual differentiation of the brain has been 
suggested by studies showing that androgen treatment of 
gonadcctomized males or females can result in the masculiniza- 
tion or del'eminization of behaviors expressed in adulthood (101). 
In rats, for example, rough and tumble play is differentiated in 
the masculine direction by dihydrotestosterone but not estro- 
gen (reviewed in 102). Androgens acting through the AR also 
appear to be particularly important in the sexual differentiation 
of the primate brain. In the rodent, some behaviors, such as 
aggression and infanticide, may be differentiated in the male 
direction by androgens acting in concert with estrogen (103). 
These studies suggest that AR should be found in the brain 
areas which are important for these behaviors during the time 
period in which they are differentiating. 
Several studies have examined the ontogeny of AR in various 
brain regions. Using in vitro binding assays, Vito and Fox (59) 
and Lieberburg et al (104) have demonstrated that AR are present 
in the developing rat brain as early as embryonic day 20. The con- 
centration of AR in the hypothalamus rises during the first four 
weeks of life to eventually achieve adult levels. Fig.4 demon- 
strates a typical developmental profile for AR in the rat hypo- 
thalamus-preoptic area in the absence of modulation by circu- 
lating steroid. In this study, male and female rats were gonadc- 
ctomized on the day of birth (PND 0). AR levels were measured 
by in vitro binding assay using 3H-R188I as the radioligand. 
Binding was determined at PND 1,12, 20, 30 and adulthood (3 
months of age, males only). Gonadectomy was performed in 
order to reduce circulating hormones which might interfere with 
the assay and to allow examination of the development of AR in 
the absence of influence by endogenous gonadal steroid hor- 
mones. Significant increases in unoccupied receptor are noted 
during the first 30 days of life and there were no sex differences. 
Highest levels were found on PND 30 and slight decreases oc- 
curred afterward to adult levels. Thus, these data suggest that 
the development of AR in the hypothalamus is delayed relative 
to that of ER. 
The development of AR in the brain has also been examined 
using immunocytochemical techniques (105). Consistent with • 
binding data, it appears that AR-immunoreactivity increases 
during postnatal life but initially appears at various times dur- 
ing postnatal development depending on the brain region. Some 
areas (ventral premammillary nucleus) show staining as early 
as PND 1 whereas other (posterior dorsal medial amygdala) do 
not exhibit staining until later in development. Similar to the re- 
sults of studies using arat model, in the ferret, increases in AR- 
immunoreactivity also occur during postnatal development 
(106). Peaks in AR-immunoreactivity occur at the time of puberty 
in the MPOA, VMN of the hypothalamus, arcuate nucleus, and 
medial amygdala, but not in the septum orBNST (106). Interest- 
ingly, AR-immunoreactivity can be further increased by expo- 
sure to long day lengths, a paradigm which hastens the onset 
of puberty in male ferrets (106).  
Recently, molecular techniques have been used to determine if       
mRNAAR is being expressed during perinatal development. Us- 
ing Northern blot analysis, mRNAAR has been detected in the 
hypothalamus as early as PND 7(107, Fig.5). Unfortunately, this    
study only used probes which detected the larger form of 
mRNAAR, thus, whether the smaller form of mRNAAR is present 
during development, or the ratio of large to small form of mRNAAR 
undergoes developmental alterations remains to be determined. 
In this study, distinct bands at earlier ages were not always con-   
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Figure 3. Film auto radio grams showing the distribution ofmRNA
AR
 in the brain of the adult male rat as detected using in situ 
hybridization analysis. The probe used in this study recognizes both the small and large forms ofmRNA
AH
. CA1, CA1 pyramidal 
layer of hippocampus; VMN, ventromedial nucleus; ma, medial amygdala; mpoa, medial preoptic area, BNST, bed nucleus of the 
stria terminalis; LS, lateral septal nucleus. 
  
sistently found, however, studies using in situ hybridization 
have shown that mRNAAK is present in specific brain nuclei as 
early as PND 0 (108). Interestingly, McAbeeef al (108) also dem- 
onstrated a sex difference in mRNAAK in the MPOA and BNST, 
hut not the VMN, with males having greater levels of receptor 
mRNA than females. The developmental profile of mRNAAR 
roughly parallels that of AR binding. The demonstration of sex 
differences in mRNAAK as early as PND 4 may be the result of 
regulation of the AR gene by the neonatal steroid hormone 
milieu. Neonatal castration of males reduces mRNAAR levels 
measured in PND 10 animals and treatment of neonatally cas- 
trated males with androgen increases the levels of mRNAAR (109) 
in the MPOA and BNSTof the PND 10 rat. How these findings 
concerning mRNAA" levels relate to AR binding or protein lev- 
els, and whether they represent early organizational events in 
the differentiation of the AR system or transient activational ef- 
fects of hormone on AR gene expression remains to be deter- 
mined.  
The monkey and guinea pig are two species in which sexual 
differentiation of the brain occurs prior to parturition and which 
depend predominantly upon non-aromatizable androgens for 
brain sexual differentiation (110). In these species, developmental 
increases in AR occur during gestation. Using in vitro binding 
assay, Handa et al (87) demonstrated that AR could be detected 
as early as day 50 of gestation (the end of the first trimester of 
pregnancy) in the fetal rhesus monkey. The greatest increases 
in AR occur throughout primate gestation (approximately 160 
days) with high levels of AR found in fetal monkey hypothala- 
mus during late gestation and further, but less substantial in- 
creases to adult levels. In the guinea pig, AR binding increases 
during the last half of gestation (E 30-60), at a time when sexual 
differentiation of the brain has been occurring (110). 
AR have also been identified in areas outside the hypothala- 
mus such as the cortex, amygdala and hippocampus (37, 90). 
Similarly to that demonstrated for ER, these areas may show de- 
velopmental changes in receptors which are different from that 
of the hypothalamic nuclei. In the rhesus monkey fetus, for ex- 
ample, a transient increase in AR ligation was demonstrated in   
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Figure 4. Ontogeny ofandrogen receptor in various brain areas as determined using in vitro binding assay. HPOA, hypothala- 
mus-preoptic area. Animals were gonadectomized on postnatal day 0 (day of birth) and sacrificed at the indicated ages. Each 
point represents the mean .±SEM of 8 - 20 determinations. There are no sex differences detected and thus, in the lower panel, data 
from males and females are pooled for graphic presentation. * represents those points significantly different (p<0.05)from the 
PND 0 group. 
 





Figure 5, Northern blot analysis of total RNA taken from various tissues and brain regions from adult animals (upper panel) and 
from hypot.halamus-preoptic area (HPOA) and anterior pituitary gland (PIT) at various ages of development, (lover panel). The 
probe used in these studies (ART) only detects the larger (11 Kb form) of the two reported species ofmRNA
AR
. HIPP, hippocam- 
pus; V.P., ventral prostate; (pnd), postnatal day. 
  
the frontal and temporal cortex toward the end of the first tri- 
mester (87). Such an AR binding has also been shown in the 
primate cerebellum during late gestation (111) .  Unlike the onto- 
genelic profile described for ER, transiently high levels of AR 
binding do not occur during the development of the rat cortex 
(Fig.4). Whether these increases in AR binding reflect an in- 
crease in sensitivity of these tissues to androgen remains to be 
determined. However, the possibility exists that transient 
changes in receptor number could define a critical period for the 
organizational actions of andros;en on certain brain structures. 
•         Regulation of androgen receptor during development 
Few studies have examined the factors which might influence 
the development of AR in the brain. In the adult, AR levels have 
been reported to be upregulated in some brain regions by cas- 
tration or estrogen treatment (90, 91), and downregulated fol- 
lowing progesterone treatment (112). In contrast, mRNAAR has 
been shown to increase (69, 98, 113), decrease (69, 114), or not 
change (115), depending on the brain region, time after castra- 
tion or hormone replacement, or method of detection. Whether   
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these same regulatory processes occur during development 
remains not known. As previously mentioned, the regulation of 
mRNAAR has been examined in.neonatal life (109). These results 
suggest that for several hypothalamic nuclei, such as theMPOA 
and BNST, that androgen exposure upregulates receptor mRNA 
expression, whereas in other brain areas, no changes were de- 
tccled. Whether androgen, or any other steroid hormone, is in- 
volved in the normal developmental increases in AR number has 
not been closely examined. However, our data (Fig.4), showing 
developmental increases in AR binding in the hypothalamus- 
prcoplic area, cortex and amygdala of animals castrated on the 
day of birth, suggest that gonadal steroid hormones are not an 
absolute requirement for increasing receptor number during de- 
velopment. 
RECENT DEVELOPMENTS AND 
IMPLICATIONS IN DIFFERENTIATION 
• The demonstration of the region-specific ontogeny of 
AR and ER in the developing brain has allowed the formulation 
of a variety of hypotheses regarding sexual differentiation of 
the brain. Advancements in our knowledge of the steroid hor- 
mone receptor biology have raised additional questions regard- 
ing the regulation and functional significance of these ligand- 
activated transcription factors in development. Although we 
now know the ontogenetic patterns of steroid hormone recep- 
tors, the cellular and molecular signals which trigger the appar- 
ent pre-programmed expression of these receptors in certain 
populations of cells during certain periods of development are 
still unknown. Recent studies have also demonstrated the pres- 
ence of multiple genes or multiple mRNA isoforms for some re- 
ceptors, such as the variety of 5'-UTR for both ER and AR. It 
remains lo be determined whether the relative amounts of these 
isoforms change during development and if so, what is the func- 
tional significance of these changes in brain development. Fi- 
nally, with the demonstration of increasing number of receptor- 
associated proteins, it is now apparent that steroid hormone re- 
ceptors do not act alone in enhancing or repressing transcrip- 
tion, but are just one part of a complex intracellular machinery 
regulating transcription. The ontogeny of these receptor-asso- 
ciated-proteins in the brain and their role in modulating steroid- 
dependent brain differentiation may ultimately prove to be a 
fertile field of research in the future.  
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